Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

EU’s New Health Crisis Response Body ‘Won’t Duplicate’ Work Of EMA And ECDC

Collaboration And Synergy Are Key To Tackling Health Emergencies

Executive Summary

The directors of two key EU agencies outlined how they would work with the new HERA, and how they see their new roles under draft legislation aimed at strengthening their responses to health crises, at the recent European Health Forum Gastein conference. The European Medicines Agency also flagged up the potential role of real-world evidence in monitoring the safety and effectiveness of COVID-19 vaccines.

You may also be interested in...



European Parliament Signs Off Regulation To Tackle Medicine Shortages

The legislation will establish a new EU platform for monitoring and reporting medicines shortages.

‘We Need Help,’ Says EMA Chief Amid COVID-19 & Burgeoning Workload

COVID-19, resource constraints and a forthcoming expansion of its responsibilities are piling the pressure on the EU regulator.

EU Bodies Agree On New Drug Shortage Monitoring Platform

Two EU institutions have reached a deal on legislation that will give the EMA a key tool for monitoring medicines supply and preventing shortages in the event of a major public health crisis such as a future pandemic.

Related Content

Topics

Latest News
UsernamePublicRestriction

Register

PS145065

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel